41
Participants
Start Date
September 19, 2022
Primary Completion Date
January 23, 2025
Study Completion Date
January 23, 2025
Purastat SAP gel application
Purastat is a fully synthetic matrix scaffold that can be applied through an endoscopic catheter. Purastat is FDA approved and commercially available. Purastat is a peptide solution that self assembles at physiological potential Hydrogen(pH) and forms a gel comprising a network of nanofibers. Its benefits in hemostasis and tissue healing and its biocompatibility have been previously demonstrated in animal models and also in human cases. When the gel comes into contact with blood or tissue fluids, the change in potential hydrogen (pH) and salt concentration causes fiber formation and gelation that block the blood vessels in the hemorrhagic area to generate hemostatic effects and also prevention of scar tissue formation.
Columbia University Irving Medical Center, New York
Johns Hopkins, Baltimore
AdventHealth Orlando, Orlando
Parkview, Fort Wayne
Baylor St. Lukes, Houston
Beth Israel Deaconess Medical Center, Boston
Lead Sponsor
AdventHealth
OTHER